Tag: safety

  • Brexit is the wrong prescription, says European pharma industry

    By Ben Hirschler LONDON (Reuters) – Britain's departure from the European Union would threaten scientific research and jeopardize the 28-nation bloc's system of drug regulation, the European pharmaceutical industry said on Wednesday. The declaration is the clearest statement yet on the issue by an industry that includes EU-based players such as Britain's GlaxoSmithKline and AstraZeneca,…